EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)

Conditions: Acute Decompensated Heart Failure Interventions: Device: Reprieve Decongestion Management System; Drug: Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide) Sponsors: Reprieve Cardiovascular, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials